TELA Bio (TELA) Short-term Investments (2019 - 2020)
TELA Bio (TELA) posted quarterly Short-term Investments of $5.3 million for Q1 2020, down 43.04% quarter-over-quarter from $9.3 million in Q4 2019.
TELA Bio (TELA) Short-term Investments (2019 - 2020) Analysis & Trends
TELA Bio's Short-term Investments history runs 2 years deep, the most recent figure standing at $5.3 million for Q1 2020.
- In Q1 2020, Short-term Investments changed N/A year-over-year to $5.3 million; the TTM figure through Mar 2020 stood at $5.3 million (changed N/A YoY), while the FY2019 annual figure was $9.3 million, changed N/A from the prior year.
- Short-term Investments for Q1 2020 stood at $5.3 million, down from $9.3 million in the prior quarter.
- The five-year high for Short-term Investments was $9.3 million in Q4 2019, with the low at $5.3 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | TELA Bio | 35.91 Mn | 5.49 Mn | 13.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 5.29 Mn |
| Dec 31, 2019 | 9.29 Mn |